Pirjo Laakkonen

16PUBLICATIONS
64CO-AUTHORS
GlycoconjugatesGene and molecular therapyPredictive and prognostic markersMolecular targetsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 29, 2026
Exclusively Chemoselective S‑Acylation for Peptide Radiolabeling Using [18F]Fluoronicotinic Acid 4‑Nitrophenyl Ester as a Prosthetic Compound.

|Jun 09, 2026
Intracranial Human BT12 Glioblastoma Xenograft is [18F]FET PET Negative but 6-[18F]Fluoronicotinic Acid PET Positive: Exploring a Novel Approach for Clinical Glioblastoma Imaging.

|Nov 03, 2025
Therapeutic Reprogramming of Glioblastoma Phenotypic States Using Multifunctional Heparin Nanoparticles.

Vadim Le Joncour, Austin D Evans, Camilla Karoliina Bergström

|Jul 03, 2025
Utilizing Monocarboxylate Transporter 1-Mediated Blood-Brain Barrier Penetration for Glioblastoma Positron Emission Tomography Imaging with 6-[18F]Fluoronicotinic Acid.

Pyry Dillemuth, Abiodun Ayo, Tomi T Airenne

|Jul 15, 2024
Switching the Chemoselectivity in the Preparation of [18F]FNA-N-CooP, a Free Thiol-Containing Peptide for Targeted Positron Emission Tomography Imaging of Fatty Acid Binding Protein 3.

Pyry Dillemuth, Petter Lövdahl, Tuomas Karskela

|Jul 24, 2023
Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model.

Hector J Monzo, Kerttu Kalander, Marko M Hyytiäinen

Pageof 3

Frequent Collaborators

8 joint publications

Vadim Le Joncour

4 joint publications

Johan Rajander

4 joint publications

Xiang-Guo Li

4 joint publications

Norbert Sewald